Target intelligence / Profile preview

WAP four-disulfide core domain protein 2 (WFDC2)

Target
WFDC2
Molecular classification
Protease inhibitor, Serine protease inhibitor, Secreted protein, Other
01

Overview

WAP four-disulfide core domain protein 2 (WFDC2), commonly known as Human Epididymis Protein 4 (HE4), is a small, secreted glycoprotein belonging to the whey acidic protein (WAP) family. Under normal physiological conditions, its expression is highly restricted, primarily found in the epithelia of the reproductive tract and respiratory system, where it plays a role in epithelial homeostasis, airway barrier development, and innate defense. However, WFDC2 is markedly overexpressed in several malignancies, most notably ovarian and endometrial cancers, where it promotes tumor cell proliferation, migration, invasion, and chemoresistance. It acts as an extracellular signaling ligand that modulates key pathways such as EGFR/MAPK, PI3K/AKT, and JAK/STAT3, and also contributes to an immunosuppressive tumor microenvironment by inducing PD-L1 expression. Clinically, HE4 is widely utilized as an FDA-approved serum biomarker for monitoring ovarian cancer recurrence and, in combination with CA125, in the Risk of Ovarian Malignancy Algorithm (ROMA). Due to its critical role in tumor progression and drug resistance, WFDC2 has emerged as a promising therapeutic target, with investigational strategies including small-molecule inhibitors (such as UR238), siRNA-mediated gene silencing, and monoclonal antibodies currently under preclinical evaluation.

Other names
Human epididymis protein 4HE4Epididymal secretory protein E4Major epididymis-specific protein E4Putative protease inhibitor WAP5WAP5EDDM4
02

Mechanism of action

Inhibition of WFDC2/HE4 expression and secretion via proteasome inhibition (UR238), gene silencing via RNA interference (HE4 siRNA), blockade of nuclear translocation via importin inhibition (Ivermectin), and transcriptional downregulation (Ketoprofen).

03

Biological functions

Signal transductionCell cycleApoptosisImmune responseCell proliferationOther
04

Disease associations

CancerInflammationOther
05

Safety considerations

Impaired lung function and respiratory failureInfertility and reproductive tract fibrosisRenal impairment and exacerbation of kidney fibrosisOff-target toxicity associated with proteasome inhibition
06

Interacting drugs

3 more in the full profile.

07

Biomarkers

Serum HE4 levelRisk of Ovarian Malignancy Algorithm (ROMA)Plasma WFDC2 levelUrine HE4 level

Beyond the preview

Go deeper on WAP four-disulfide core domain protein 2 (WFDC2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on WAP four-disulfide core domain protein 2 (WFDC2).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call